Plans for Highway Detour in Nevada Stalled by Natural Asbestos Discovery
Discovery of Natural Asbestos in Eldorado Valley Halts Plans for $490 Million Bypass Project
Category: asbestos exposure
University of Pennsylvania Receives $10 Million Grant to Fund Four Years of Asbestos Studies
$10 Million Grant Given to University of Pennsylvania for Asbestos Research
Verdict in Georgia Pacific Asbestos Case Affirmed in Texas Supreme Court
Texas Supreme Court Upholds Lower Court’s Decision in Asbestos Case
Company Owner Pleads Guilty to Illegal Asbestos Disposal in Two Colorado Counties
Two Colorado Companies to Pay $1 Million for Illegally Disposing of Asbestos
University of Pennsylvania’s Personalized Cellular Therapy Receives FDA’s Breakthrough Therapy Designation
FDA Designates New Leukemia Treatment as Breakthrough Therapy
Two Swiss Companies to Pay $90.5 Million to Families of Mesothelioma Victims
Eleven New Jersey Families Awarded $90.5 Million in Asbestos Case
Asbestos Case Plaintiffs Awarded $4.5 Million Have Verdict Reversed
Philadelphia Appeals Court Reverses Guilty Verdict in Asbestos Case
Judge Does Not Accept Expert Testimony as New Evidence in Widow’s Asbestos Case
Widow Denied Reconsideration After Mistrial in Asbestos Case
Defendant in Asbestos Case May Have No-Contest Plea Deal Withdrawn Due to Claims of Innocence
Merced County Prosecutors File Motion to Withdraw Plea Deal in Asbestos Case
Flawed Permitting System May Have Led to Asbestos Exposure, Say Southeast Portlanders
Southeast Portland Residents Call for City to Regulate Asbestos Abatement
Pfizer Wins Third-Straight Asbestos Case
Maryland Judge Dismisses Widow’s Asbestos Suit Against Pfizer
Plaintiff Appeals Ruling in Asbestos Case, Appellate Court Reverses Decision
California Appeals Court Reverses Trial Court’s Ruling in Asbestos Case
Mesothelioma Study Identifies Four Biomarkers That May Help Speed Up Diagnoses and Treatment
Scientists Identify Four Biomarkers That May Improve Mesothelioma Diagnostics
Fresno County Supreme Court Awards $10.9 Million to Victim’s Family in First Mesothelioma Verdict
Jury Awards Victim’s Family $10.9 Million in Fresno’s First Mesothelioma Verdict
Cancer Drug Developer Verastem Publishes Paper on Study of Merlin Loss
Scientists Publish Paper Declaring Merlin Deficiency as Predictor of Cancer Drugs’ Efficacy